Drugs / Unconjugated Hib vaccine (plain PRP)
last change Aug 2004 re-read 2 minutes ago

Unconjugated Hib vaccine (plain PRP)

Vaccine

Investigated by
GlaxoSmithKline

Trials 1 · a red edge is where a trial was stopped

2003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT01061541 Aug 2003 → Jan 2004 haemophilus infectious disease GlaxoSmithKline Completed No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Unconjugated Hib vaccine (plain PRP) ClinicalTrials.gov intervention name — accepted as the source's own label NCT01061541
Modality Vaccine “Unconjugated Hib vaccine (plain PRP)” NCT01061541
Route Intramuscular “One dose as intramuscular injection at 10 months of age” NCT01061541